Please find more information here:
Announcements
Calendar & Events
Financials and Reports
Analysts
The Share
Governance
General Meetings
Shareholder Portal
IPO 2018

ViroGates is an international medical technology company headquartered in Denmark and since June 2018 listed on Nasdaq First North Growth Market, Denmark (Ticker code: VIRO).

We aim to be perceived as a trustworthy and open company and will communicate all information correctly, in a balanced, transparent and timely way and simultaneously to investors, equity analysts and other stakeholders in the financial markets to facilitate regular trading and fair pricing of the company’s shares.

Investment highlights

  • In commercialization phase with approved product portfolio with strong patents
  • EUR ~250 million initial market potential with short-term focus on European Acute Care – Global value of addressable Acute Care market EUR +1 billion
  • Cash at hand sufficient to lead to profitability
  • Almost 40 hospitals in eight countries in Europe currently using the Company’s products
  • Significant clinical data, documentation and 550 peer reviewed articles to support the value of suPAR

Strategic objectives

  • 40 paying hospital accounts by the end of 2020
  • Cash flow positive by the end of 2020

 

Read Announcements

Latest Reports

 

 

Contact Investor Relations
CEO Jakob Knudsen
Tel. +45 2113 1336
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Certified Advisor
Västra Hamnen Corporate Finance
Per Lönn
Jungmansgatan 12
211 19 Malmö
Tel. (+46) 40 200 250
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.